Laura Joszt, MA

FDA approves mosunetuzumab's subcutaneous formulation, enhancing treatment access for relapsed follicular lymphoma.

Costs remain the top concern of healthcare purchasers of pharmacy benefits, but employers are also concerned with ensuring appropriate use of medication and adherence to medication, according to a new report from the Pharmacy Benefit Management Institute (PBMI).

A policy from the Trump administration to benefit patients and alleviate the high cost of prescription drugs would eliminate rebates from pharmaceutical companies to pharmacy benefit managers.

New research has identified the origins of acute myeloid leukemia, which can be detectable more than 5 years before the disease develops.

New research identified predictors of long-term survival and health-related quality of life in patients with newly diagnosed multiple myeloma.

Currently, many patients experience a more than 3-month delay until their diagnosis is confirmed.

Quizartinib has prolonged survival in patients with a rare and deadly form of acute myeloid leukemia.

Using gene editing to remove CD33, a protein targeted to treat acute myeloid leukemia with chimeric antigen receptor (CAR) T cells, from healthy stem cells could reduce toxicity experienced by CAR T-cell therapy.

From 1990 to 2016, incident cases and deaths from multiple myeloma have grown substantially.

Patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL) who were treated with inotuzumab ozogamicin (InO) indicated better quality of life, functioning, and symptom scores compared with patients receiving standard-of-care chemotherapies.

Humana has designed a new value-based care maternity bundled payment model to improve quality, outcomes, and cost across the entire perinatal episode of care for commercial group members with low- to moderate-risk pregnancies.

There are 40 genes involved in the development of multiple myeloma, according to new research.

Although the risk of neurocognitive issues is common in survivors of childhood lymphoblastic leukemia (ALL), a new study suggests that the risk may actually begin before treatment.

Reports from The Lancet's Taskforce of Non-Communicable Diseases highlight the potential health and economic impact of taxes on soft drinks, alcohol, and tobacco.

The rivaroxaban plus aspirin combination therapy to treat patients with stable coronary or peripheral artery disease showed such benefits in the COMPASS trial that it should become the standard of care.

In this clip, Deepak Bhatt, MD, discusses the results of the COMPASS (Cardiovascular OutcoMes for People using Anticoagulation StrategieS) trial, presented at the European Society of Cardiology Congress 2017, held August 26-30 in Barcelona, Spain.

Prior to the president's final State of the Union address, Democrats announced new plans to investigate drug prices in 2016.

More than 5 years after the Affordable Care Act was passed, Republicans are sending a bill to unravel the healthcare law to the president's desk. President Obama has already vowed to veto the bill.

While the prevalence of problems paying medical bills may be greater in certain groups compared with others, almost anyone can experience difficulty paying medical bills, according to the results of a survey from Kaiser Family Foundation/New York Times.

Several economists have proposed a way to level the financial playing field between employer and individual health insurance markets.

An analysis revealed growing evidence of improved access to and affordability of care after the implementation of the Affordable Care Act, but gaps remain, especially for low-income adults.

Democrats and Republicans agreeing on something having to do with the Affordable Care Act is unusual, but there is one aspect of the health care law that both parties feel the same about: the excise, or Cadillac, tax.

A measure to delay the unpopular "Cadillac tax," part of President Obama's health reform law, overwhelmingly passed the Senate by a 90-10 vote on Thursday.

UnitedHealth is the only company to announce it may depart from insurance exchanges.

In California, a class action lawsuit has been filed on behalf of thousands of Blue Cross beneficiaries living with hepatitis C who were denied treatment.

Overall satisfaction with the total cost of health care has been stable for 14 years.

Pfizer and Allergan announce $160 billion merger, which is the second-largest in the healthcare industry's history and the largest to use a controversial tax-saving strategy.

CMS aims to provide choice and competition for consumers and improve the consumer experience.

Express Scripts removes specialty pharmacy Linden Care from its network.

Initiative does not prohibit the purchase or sale of private coverage duplicating the public plan.